Who
Sean Maduck
Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Corcept Therapeutics.
In numbers
- Trades disclosed
- 338
- Buys
- 0
- Sells
- 53
- Bought
- $0
- Sold
- $79.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Feb 2018
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $203K24,587 at $8.27 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.8M15,843 at $116.12 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.0M8,744 at $116.55 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —24,587 at $0.00 | filing |
| 1 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $3,416413 at $8.27 | filing |
| 1 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $48K413 at $115.54 | filing |
| 1 Oct 2026filed 5 Oct 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —413 at $0.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $13K117 at $113.38 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $13K117 at $113.38 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $207K25,000 at $8.27 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.3M11,730 at $113.94 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.3M10,989 at $114.71 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $264K2,281 at $115.61 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code A | $17K150 at $113.38 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —150 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $207K25,000 at $8.27 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.3M11,730 at $113.94 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.3M10,989 at $114.71 | filing |
News
No headline names them, or the companies they trade most, lately.